all items  in current results   Refine your search within these categories: 1. Human Genes (group results) 1-acylglycerol-3-phosphate O-acyltransferases [HGNC:AGPAT] (15) 5-HT (serotonin) receptors [HGNC:HTR] (22) 7TM orphan receptors [HGNC:O7TM] (1) A-kinase anchor proteins [HGNC:AKAP] (44) Abhydrolase domain containing [HGNC:ABHD] (9) Acetylcholine receptors, nicotinic [HGNC:CHRN] (22) Acid-sensing (proton-gated) ion channels [HGNC:ASIC] (1) Actin related protein 2/3 complex subunits [HGNC:ARPC] (5) Acyl-CoA synthetase family [HGNC:ACS] (22) Acyl-CoA thioesterases [HGNC:ACOT] (14) more... 2. Interaction: Human Genes and Chemicals: all > Decreases > response to substance 3. Bioactivity 4. Semantic Terms (group results) Entity [STY:T071] (33) A. Anatomy (group results) Body Regions [MESH:D001829] (96) Cardiovascular System [MESH:D002319] (97) Cells [MESH:D002477] (99) Digestive System [MESH:D004064] (74) Embryonic Structures [MESH:D004628] (17) Endocrine System [MESH:D004703] (37) Hemic and Immune Systems [MESH:D006424] (35) Integumentary System [MESH:D034582] (15) Musculoskeletal System [MESH:D009141] (97) Nervous System [MESH:D009420] (60) more... B. Organisms C01. Bacterial Infections and Mycoses (group results) Bacterial Infections [MESH:D001424] (116) Brain Abscess [MESH:D001922] (2) Central Nervous System Infections [MESH:D002494] (1) Infection [MESH:D007239] (114) Mycoses [MESH:D009181] (62) C02. Virus Diseases (group results) Virus Diseases [MESH:D014777] (116) C03. Parasitic Diseases (group results) Parasitic Diseases [MESH:D010272] (115) C04. Neoplasms (group results) Neoplasms [MESH:D009369] (116) C05. Musculoskeletal Diseases (group results) Musculoskeletal Diseases [MESH:D009140] (116) C06. Digestive System Diseases (group results) Digestive System Diseases [MESH:D004066] (116) C07. Stomatognathic Diseases (group results) Stomatognathic Diseases [MESH:D009057] (116) C08. Respiratory Tract Diseases (group results) Respiratory Tract Diseases [MESH:D012140] (116) Z. Exceptions (102) C09. Otorhinolaryngologic Diseases (group results) Otorhinolaryngologic Diseases [MESH:D010038] (115) C10. Nervous System Diseases (group results) Nervous System Diseases [MESH:D009422] (116) Z. Exceptions (115) C11. Eye Diseases (group results) Eye Diseases [MESH:D005128] (116) Z. Exceptions (35) C12. Male Urogenital Diseases (group results) Male Urogenital Diseases [MESH:D052801] (116) C13. Female Urogenital Diseases and Pregnancy Complications (group results) Female Urogenital Diseases [MESH:D052776] (116) Pregnancy Complications [MESH:D011248] (116) Z. Exceptions (96) C14. Cardiovascular Diseases (group results) Cardiovascular Diseases [MESH:D002318] (116) Z. Exceptions (110) C15. Hemic and Lymphatic Diseases (group results) Hematologic Diseases [MESH:D006402] (116) Lymphatic Diseases [MESH:D008206] (116) Z. Exceptions (69) C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities: all > Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] > Congenital Abnormalities [MESH:D000013] > Nervous System Malformations [MESH:D009421] > Agenesis of Corpus Callosum [MESH:D061085] (group results) Absent corpus callosum cataract immunodeficiency [MESH:C535566] (5) Acrocallosal Syndrome [MESH:D055673] (20) Chudley-Mccullough syndrome [MESH:C535459] (24) Combined Oxidative Phosphorylation Deficiency 2 [MESH:C566468] (9) Corpus callosum agenesis neuronopathy [MESH:C536446] (8) Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia [MESH:C564509] (6) Corpus Callosum, Partial Agenesis of, X-Linked [MESH:C564115] (18) Donnai-Barrow syndrome [MESH:C536390] (15) Holoprosencephaly [MESH:D016142] (82) Opitz-Kaveggia syndrome [MESH:C537923] (35) more... C17. Skin and Connective Tissue Diseases (group results) Connective Tissue Diseases [MESH:D003240] (116) Skin Diseases [MESH:D012871] (116) C18. Nutritional and Metabolic Diseases (group results) Metabolic Diseases [MESH:D008659] (116) Nutrition Disorders [MESH:D009748] (116) Z. Exceptions (77) C19. Endocrine System Diseases (group results) Endocrine System Diseases [MESH:D004700] (116) Z. Exceptions (28) C20. Immune System Diseases (group results) Immune System Diseases [MESH:D007154] (116) Z. Exceptions (54) C21. Disorders of Environmental Origin (group results) Disorders of Environmental Origin [MESH:D007280] (2) C22. Animal Diseases (group results) Animal Diseases [MESH:D000820] (115) C23. Pathological Conditions, Signs and Symptoms (group results) Pathologic Processes [MESH:D010335] (116) Pathological Conditions, Anatomical [MESH:D020763] (116) Signs and Symptoms [MESH:D012816] (116) C24. Occupational Diseases (group results) Occupational Diseases [MESH:D009784] (114) Z. Exceptions (98) C25. Chemically-Induced Disorders (group results) Drug-Related Side Effects and Adverse Reactions [MESH:D064420] (116) Poisoning [MESH:D011041] (116) Substance-Related Disorders [MESH:D019966] (116) C26. Wounds and Injuries (group results) Wounds and Injuries [MESH:D014947] (116) Z. Exceptions (113) D01. Inorganic Chemicals (group results) Acids [MESH:D000143] (1) Arsenicals [MESH:D001152] (4) Boron Compounds [MESH:D001896] (1) Cadmium Compounds [MESH:D019187] (1) Chlorine Compounds [MESH:D017606] (3) Chromium Compounds [MESH:D017608] (1) Electrolytes [MESH:D004573] (6) Elements [MESH:D004602] (11) Free Radicals [MESH:D005609] (1) Iron Compounds [MESH:D058085] (1) more... D02. Organic Chemicals (group results) Organic Chemicals [MESH:D009930] (63) D03. Heterocyclic Compounds (group results) Heterocyclic Compounds [MESH:D006571] (28) D04. Polycyclic Compounds (group results) Polycyclic Compounds [MESH:D011083] (17) D05. Macromolecular Substances D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results) Hormones [MESH:D006728] (3) D08. Enzymes and Coenzymes D09. Carbohydrates (group results) Carbohydrates [MESH:D002241] (3) D10. Lipids (group results) Lipids [MESH:D008055] (3) D12. Amino Acids, Peptides, and Proteins (group results) Amino Acids [MESH:D000596] (1) Peptides [MESH:D010455] (2) D13. Nucleic Acids, Nucleotides, and Nucleosides (group results) Nucleosides [MESH:D009705] (3) Nucleotides [MESH:D009711] (1) D20. Complex Mixtures (group results) Complex Mixtures [MESH:D045424] (2) D23. Biological Factors (group results) Biological Factors [MESH:D001685] (8) D25. Biomedical and Dental Materials D26. Pharmaceutical Preparations (group results) Plant Extracts [MESH:D010936] (1) D27. Chemical Actions and Uses (group results) Pharmacologic Actions [MESH:D020228] (15) Specialty Uses of Chemicals [MESH:D020313] (2) Toxic Actions [MESH:D004786] (3) E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results) Diagnosis [MESH:D003933] (102) F. Psychiatry and Psychology (group results) Behavior and Behavior Mechanisms [MESH:D001520] (105) Mental Disorders [MESH:D001523] (112) Psychological Phenomena and Processes [MESH:D011579] (8) G. Phenomena and Processes (group results) Chemical Phenomena [MESH:D055598] (7) Circulatory and Respiratory Physiological Phenomena [MESH:D002943] (63) Genetic Phenomena [MESH:D055614] (99) Musculoskeletal and Neural Physiological Phenomena [MESH:D055687] (20) Physiological Phenomena [MESH:D010829] (69) Reproductive and Urinary Physiological Phenomena [MESH:D012101] (5) I. Anthropology, Education, Sociology and Social Phenomena J. Technology, Industry, Agriculture (group results) Technology, Industry, and Agriculture [MESH:D013676] (1) N. Health Care Recently Viewed Items Go to Item History

These terms define your current search. Click the × to remove a term. 2. Interaction: Human Genes and Chemicals: Decreases > response to substance × C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities: Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] > Congenital Abnormalities [MESH:D000013] > Nervous System Malformations [MESH:D009421] > Agenesis of Corpus Callosum [MESH:D061085] × Items 1 to 40 of 116 results Group by: 2. Interaction: Human Genes and Chemicals, C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities Sort by: MeSH_UID, MeSH_NAME   1 41 81 MESH:C004648   testosterone enanthate C004648               MESH:C004925   methylmercuric chloride C004925               MESH:C006632   arsenic trioxide C006632               MESH:C006780   bisphenol A C006780               MESH:C008493   methylselenic acid C008493               MESH:C009277   sodium arsenate C009277               MESH:C009618   O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate C009618               MESH:C011272   perfosfamide C011272               MESH:C012589   trichostatin A C012589               MESH:C012796   2-butenal C012796               MESH:C014347   decitabine C014347               MESH:C015001   arsenite C015001               MESH:C016601   afimoxifene C016601               MESH:C017906   3-dinitrobenzene C017906               MESH:C017947   sodium arsenite C017947               MESH:C018021   cobaltous chloride C018021               MESH:C025462   sulindac sulfide C025462               MESH:C025589   ochratoxin A C025589               MESH:C027576   4-hydroxy-2-nonenal C027576               MESH:C029938   nickel sulfate C029938               MESH:C030110   oxaliplatin C030110               MESH:C030973   cupric oxide C030973               MESH:C031895   lead chromate C031895               MESH:C032668   1-nitropyrene C032668               MESH:C039671   ciglitazone C039671               MESH:C039726   artesunate C039726               MESH:C049584   2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine C049584               MESH:C051890   irinotecan C051890               MESH:C056507   gemcitabine C056507               MESH:C057693   troglitazone C057693               MESH:C059514   resveratrol C059514               MESH:C061133   tamibarotene C061133               MESH:C064769   N-acetylsphingosine C064769               MESH:C070081   fulvestrant C070081               MESH:C072553   benzyloxycarbonylleucyl-leucyl-leucine aldehyde C072553               MESH:C089730   rosiglitazone C089730               MESH:C103303   alitretinoin C103303               MESH:C111237   vorinostat C111237               MESH:C113580   U 0126 C113580               MESH:C400082   bortezomib C400082               1 41 81